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Background: To examine the presence of diabetic retinopathy in a female rat model of type 2 diabetes fed on a
high-fat diet (HFD).
Methods: Wistar rats were injected with streptozotocin (STZ) at the age of two days and fed on an HFD from eight
weeks onwards. Five diabetic animals were euthanized at 110 weeks of disease, together with a control group of
age-matched, non-diabetic animals. A group of diabetic animals at 57 weeks of disease was included for comparison.
Cross sections of the rats’ corneas, iris and retinas were histologically examined and analysed by immunohistochemistry
and immunofluorescence, using glial-fibrillary-acidic-protein (GFAP), the vascular endothelial growth factor (VEGF) and
the Von Willebrand factor (vWF). The trypsine digestive technique was used for the pericytes count.
Results: Neovascularization was only found in the retinas, irises and corneas of the diabetic animals of 110 weeks of
disease. There was also a significantly lower number of pericytes in these animals than in the controls.
Conclusion: The female rat model of type 2 diabetes fed on an HFD may prove useful in evaluating the mechanisms
involved in diabetic retinopathy, together with strategies to reduce its severity.
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The prevalence of diabetes is increasing worldwide [1,2].
Factors involved in this special epidemia include a sed-
entary lifestyle, a fatty diet and being overweight. As a
result, secondary diabetic complications have also risen
[2]. Diabetic retinopathy is still the main cause of blind-
ness in adults, despite important therapeutic advances.
The type 1 diabetes rat model has been widely used by
visual scientists to analyse molecular mechanisms associ-
ated with diabetic retinopathy [3]. These animals are ex-
tremely fragile and die early, before retinal angiogenesis
occurs. However proliferative retinopathy has not yet
been reported in type 2 diabetic rats, who have a longer
and healthier life [3-5]. This motivated investigators to seek
new rat models of type 2 diabetes in which proliferative* Correspondence: jgallo06@gmail.com
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reproduction in any medium, provided the orchanges could be studied. It is worth mentioning that chor-
oidal and retinal neovascularization have been described
in rat models without diabetes [3,6], unveiling mecha-
nisms similar to those reported in proliferative diabetic
retinopathy [7].
In a previous study, we aimed to develop a prolifera-
tive diabetic retinopathy animal model in male type 2
diabetic rats fed on a high-fat diet (HFD) with a follow-
up of 90 weeks. However, no proliferative changes were
found (unpublished data). For this reason, we decided to
conduct a new and longer study. This time the investi-
gation was performed in a group of female rats, due to
recent reports that higher levels of hyperglycaemia have
been observed in female than male rats [8,9]. Female
rats may develop much more severe diabetes [8,10]. In
humans, recent investigations carried out in postmeno-
pausal women reported an inverse relationship between
serum concentrations of sex hormone binding globulin
(SHBG) and the risk of clinical diabetes [11,12]. It is
also known that oestrogens enhance angiogenesis underl Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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ever, it should be noted that a difference in diabetes
growth between male and female rats is still a controver-
sial subject.
This paper reports the outcome of a research study
carried out on female type 2 diabetic rats fed on an
HFD, with a follow-up of 110 weeks (two years), that
developed proliferative changes in the retina, iris and
cornea. To our knowledge, this is the first report to
demonstrate the presence of proliferative diabetic ret-
inopathy and neovascularization of the anterior segment
in rats.
Methods
Rat model of diabetes
Pregnant Wistar Rats (provided by CONEA, Buenos
Aires) were housed in the animal facilities section of the
School of Biomedical Sciences of Austral University, at
21 ± 1°C on a 12-h light–dark cycle. They were exam-
ined daily until delivery (at 9 am and 6 pm). Two days
after birth, the newborn rats were intraperitoneally injected
with streptozotocin (STZ) (45 mg/kg) (Sigma Lab), in
0.1 ml of a 0.1 M solution of citrate buffer of 154 mm of
NaCl at 4.5pH [9,15,16]. The rat pups remained with the
mothers until they were 21-days-old. Eight weeks later,
the STZ-treated animals were fed with a home-made
HFD. Table 1 shows the composition of the diet, which
was prepared every week and stored at −7°C. Glycaemia
levels were measured one week after starting the diet and
every month thereafter. Blood samples of 32 μl were col-
lected by tail snipping and tested using the Reflotron Sys-
tem Boehringer Mannheim. High levels of glycaemia
(160-220 mg/dl) were found in rats fed on the HFD [17].Table 1 The composition of the high-fat diet (HFD) and
standard diet
HFD Standard
Total Subtotal Total Subtotal
Carbohydrates 28.8% 54.2%
Protein 23.6% 23.6%








Ions Calcium 1.6% 1.4%
Sodium 0.05% 0.05%
Magnesium 0.18% 0.18%Two groups of twelve and five animals were euthanised at
57 and 110 weeks of diabetes, respectively.
Control rats
Non-diabetic animals with no STZ injection were fed on
standard food with a 2.71% fat content (Table 1). Their
levels of glycaemia were normal (80-95 mg/dl). Twelve
controls animals were euthanized at 62 weeks old and
five at 115 weeks old.
Animals used in the study were handled according to
the Association of Research in Vision and Ophthalmol-
ogy (ARVO) Statement for the use of animals in oph-
thalmic research.
Clinical parameters
Each animal was weighed using a standard scale at eight
weeks of life and before death. Lipidaemia levels were
determined using the Reflotron System every month and
before the animal was euthanised.
Fatty acid profile
The chemical compound of the HFD and conventional
diets are shown in Table 1. In brief, the HFD contained
25.6% of fat (46.4% saturated, 47.5% monosaturated and
6.3% polysaturated) while the conventional diet con-
tained 2.71% of fat (24.2% saturated, 30.2% monosa-
turated and 45.6% polysaturated). The diet’s chemical
compound was analysed using animal and vegetable fats
and oil-analysis by gas chromatography of methyl esters of
fatty acids according to The International Organization for
Standardization (ISO 5508: 1990-E).
Clinical photographs and gross sections
Clinical photographs were taken of the animals when
they were still alive and before anaesthesia. For the gross
sections, we removed the ocular globe, then used a 30G
needle to inject an air bubble through the corneal limbus
into the anterior chamber to make the presence of blood
vessels in the cornea more evident. Both pictures were
taken with a NIKON digital camera DS3000 (Tokyo, Japan)
using the macro function.
Histological examination
The rats were anaesthetised using 350 mg/kg of chloral
hydrate, delivered by an intraperitoneal injection. The
eyes were removed and fixed in 4% paraformaldehyde
(Sigma-Aldrich, St Louis, MO). Rats were then eutha-
nised using an overdose of chloral hydrate. The eyes
were left for one day for fixation, then immersed for
cryoprotection in four concentrations of glucose (5%
overnight and 7.5%, 10% and 20% for two hours each)
and interlocked with resin. Ten-micron cryosections
were obtained (Shandon AS325 Retraction) and stained
with haematoxylin and eosin (H&E) as well as periodic
Table 2 Weight, glycaemia, trygliceridaemia and
cholesterolaemia in diabetic and control rats
Group No. rats WA WD Parameters *(SD)
Weight** Gl*** Tri*** Ch***
CONTROL 12 8 – 320(30) 99.7(31.9) N-M N-M
DBT-HFD 12 8 0 340(28) 125(21) N-M N-M
CONTROL 12 62 – 524(80) 86(5.2) 91 119
DBT-HFD 12 65 57 449(76) 158(22) 114 115
CONTROL 5 115 – 266(45) 100(18.8) 113 118.5
DBT-HFD 5 118 110 279(62) 232(81) 122 115
N-M: not measured; WD: weeks on HFD; WA: weeks of age; Gl: fasting
glycemia; Tri: triglyceridaemia; Ch: cholesterolaemia; * Mean (standard
deviation); **gr; ***mg/dl.
Diabetic animals with fasting glycaemia < 160 mg/dl were excluded.
Control animals with fasting glycaemia > 130 mg/dl were not included in
the study.
Figure 1 Anterior segment vessels. A: picture of in vivo 110-week-old anim
(arrow head). B: in vivo 110-week-old control animal. C: gross section from
D: Magnification from the C photograph showing the presence of vessels in
haematoxylin and eosin (F, I, J) iris staining from a LT-DBT animal (E, G, H, K
J: control iris from a non-diabetic age-matched rat. Bar 20 μm. L: The iris thi
LT-DBT mean 14.11 ± 1.010 (N = 50), control mean 6.557 ± 0.5647 (N = 47). L
corneas. LL and M: vessels in the corneal stroma of LT-DBT animals, LL1 and
N: normal control cornea from a LT-Control rat. Bar 20 μm.
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an Eclipse Nikon E800 Microscope (Tokyo, Japan). At
least five sections per eye were examined.
Immunohistochemical and immunofluorescent analyses
The eyes were removed and fixed for 48 hours in 4%
paraformaldehyde (Sigma-Aldrich, St Louis, MO). They
were then immersed for cryoprotection in four concentra-
tions of glucose (5% overnight and 7.5%, 10% and 20% for
two hours each) and interlocked with resin. Ten-micron
sections were obtained and fixed on polylisine-treated glass
slides (Shandon AS325 Retraction).
For immunohistochemistry, the sections were first
incubated in biotinylated goat anti-mouse IgG, then in an
avidin-biotin peroxidase complex kit and finally in 3.3′-
diaminobenzidine (DAB)/nickel solution. For immu-
nofluorescence, axial sections were revealed using the
secondary antibody goat-anti mouse with fluorescein.al (LT-DBT). The eye shows vessels in the cornea (arrow) and cataract
an enucleated LT-DBT eye with an air bubble in the anterior chamber.
the cornea (arrow). Light microscopy, PAS and eosin (E, G, H, K) and
). Arrows indicate the presence of abnormal vessels in the iris. F, I and
ckness is higher in the LT-DBT rats represented in μm. ***p < 0.0001,
ight microscopy; haematoxylin and eosin and PAS and eosin stained
M1, 2 and 3 are magnification of vessels within the corneal stroma.
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Eclipse Nikon Microscope (Tokyo, Japan).
GFAP expression was analysed using the primary mono-
clonal antibody anti-GFAP (BIOGENEX, 4600 Norris
Canyon Road, San Ramon, CA, USA).
The immunoreactivity of the vascular endothelial growth
factor (VEGF) was examined using the anti-VEGF poly-
clonal antibody (Santa Cruz Biotechnology Inc, 2145
Delaware Avenue, Santa Cruz, CA) and the anti human-
vWF (Sigma-Aldrich, St Louis, MO: f3520) was used for
the Von Willebrand factor (vWF).
Trypsin digestive technique
After the cornea was incised, the eyeball was fixed by
immersing it, for a minimum of four hours, in 4% for-
malin buffered with 50 mM Na-K phosphate (pH 7.2).
The retina was dissected and then placed in the 4% buff-
ered formalin for a further hour. The retina was cut into
a segment adequate for handling and washed overnight
in running water. After that, it was incubated at 37°C in
a solution of 3% trypsin (Difco 1:250) and 0.1 M tris buf-
fer (pH 7.8) for one to three hours. The incubation was
finished when the medium became cloudy and the tissueFigure 2 Incidence: statistical analyses; the one-way ANOVA (and non
multiple comparisons post test. (A) represents the corneal neovasculariz
iridis, (D) presence of pre-retinal neovascularization. (p < 0,01).showed signs of digestion. The internal limiting mem-
brane was peeled off in one sheet [18,19]. The network
of vessels was freed of adherent retinal tissue by gentle
shaking, mounted on a clean slide and allowed to dry.
The preparation was stained with PAS and eosin.
Image analysis: count of pericytes
Image analysis measurements were made using a KS400
system (Kontron Elektronic/Zeiss, Eching, Germany) and a
Nikon DXM 1200 digital camera (Tokyo, Japan) mounted
onto an Eclipse Nikon E-800 microscope for image acqui-
sition. Briefly, images were digitalised in a rectangular
frame of 1280 x 960 pixels using the 40X objective in
the photo mode of illumination intensity. To adjust for
possible defects in the illumination of the optical path-
way, a low-pass image was produced for subtraction and
background shading correction. After that, a grey value
for image segmentation was interactively chosen. In
order to define a threshold grey level, all the pixels whose
grey value informative content was lower or higher than
the segmentation grey were set to white and the others
were set to black. The pericytes were counted in ten
randomly-selected sections of each retina by one observer.parametrics) was used in all the cases with the Newman-Keuls
ation, (B) intraretinal microaneurysms and neovessels, (C) rubeosis
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tive capillary density (number of cells per millimeter
squared of capillary area – 3 pixels2 of capillary area =
1 mm2). The mean value was calculated in each animal.
Samples were evaluated in a masked fashion. Statistical
analysis was carried out using T-test analysis. All ele-
ments outside of the two standard deviations (SD) were
eliminated.
Iris thickness measurement
Thickness measurements of the iris were made in all
Long-term diabetics animals (LT-DBT) and control ani-
mals of 110-weeks-old. We used ten samples (100x) of
each iris from the pupil to the iris base, distributed be-
tween 300 μm in each sample. Samples were evaluated
in a masked fashion. The image analyses were done with
Image-J programme (Image Processing and Analysis in
Java, NIH) and were performed using a Nikon DXM
1200 digital camera (Tokyo, Japan) mounted onto an
Eclipse Nikon E-800 microscope for image acquisition.
Images were digitalised in a rectangular frame of 1280 x
960 pixels using the 100x. To adjust for possible defects
in the illumination of the optical pathway, a low-pass
image was produced for subtraction and background
shading correction. The statistical analysis was the same
as we used for the pericytes.Figure 3 Posterior segment. Retina light microscopy: PAS and eosin (A a
retinas. A, B, C and D are retinas from different LT-DBT animals. Arrows in pictu
layer. E, F, G and H show the LT-Control retina. Bar 20 μm. Optic nerve. Haema
sections of the optic nerve, I and J: LT-DBT animals with vessels from nerve toResults
Diabetic rats had higher glycaemia levels (range 140-
416 mg/dl and mean 232 mg/dl, SD 81.9) at 110 weeks
of diabetes compared to age-matched control rats (range
80-120 mg/dl and mean 100.5 mg/dl, SD 18.8). Higher
levels of triglyceridaemia were observed in the diabetic
animals than the controls (Table 2). The chemical com-
position of the diet is shown in Table 1.
When we looked at the anterior segment, the clinical
photographs and gross sections showed the presence of
cataracts in the five LT-DBT (110 weeks old), in two out
of five 110-week-old control rats and in none of the
short-term diabetic rats (ST diabetics, 57 weeks old) and
62-week-old control rats. The difference between LT-
DBT rats and the other animal groups was statistically
significant (p < 0.05) (Figure 1). Corneal neovasculari-
zation was seen in three out of the five LT diabetics.
Neovessels were observed in the periphery and centre
of the cornea, with an extension of at least one quad-
rant in each animal (Figure 1: A,C and D). The irises of
all LT diabetic animals were significantly thicker than
the controls due to the presence of abnormal vessels
(Figure 1: L)(p = 0.0309, pair t-test; p < 0.0001, LT-DBT
mean 14.11 μm± 1.010 N = 50, control mean 6.557 μm±
0.5647 N = 47). At least five neovessels were found in each
iris section (Figure 1: E-K). Corneal histological analysisnd C) and haematoxylin and eosin (B, D, E, F, G and H) stained
re A, B, C and D are pointing to vessel dilations in the outer plexiform
toxylin and eosin (I and K) and PAS and eosin (J) staining from transverse
vitreous (arrows) and K: normal optic nerve from LT-Controls. Bar 20 μm.
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(Figure 1: LL and M and Figure 2). No neovessels in the
cornea and iris were seen in either the controls or the ST
diabetics (Figure 2).
When we looked at the posterior segment, we saw intra-
retinal neovessels in all LT diabetic animals (Figure 3).
Vessel dilation or microaneurysms were found in four ani-
mals (Figure 2; Figure 3: A - D). None of these findings
were seen among the controls or ST diabetics. Pre-retinal
vessels were histologically seen near the optic nerve in two
LT diabetics (Figure 2; Figure 3: I and J).
The immunoreactivity for VEGF and vWF in the ret-
ina, iris and cornea was analysed by anti-vWF antibodies
(Figure 4, column 1) and anti-VEGF (Figure 4, column 2).
We only observed up-regulation of vWF and VEGF in theFigure 4 Immunofluorescence of retina (A, B, C), iris (D, E, F) and cornea
diabetic (rows: B, E and H) and a LT-Control animal (rows C, F and I). Imm
(vWF) (column 1 green) and VEGF (column 2 red) and merge picture (column
layer (FL) and arrow head in outer plexiform layer (OPL); in picture A2 the arro
picture with arrow in the OPL that indicates the co-expression of the two
the expression of vWF and VEGF in the iris. In pictures G1, G2 and G3 the arro
stroma. 57-week-old animals. Immunofluorescent staining of transverse retinal
for vWF (green) and VEGF (red) and merge. At this time we found no abnor
staining of transverse retinal section in picture C1, C2 and C3: iris in F1, F2 an
and merge. No expression was found in control animals. Bar 20 μm.LT diabetics (Figure 4: A1, A2, D1, D2 and G1, G2). The
retina showed up-regulation of vWF in vessels localised in
the fibre layer (FL) and in the outer plexiform layer (OPL)
(Figure 4: A1), while VEGF up-regulation was found in the
OPL (Figure 4: A2). In this layer, co-localisation of vWF
and VEGF was observed (Figure 4: A3). A similar co-
expression of the two proteins (vWF and VEGF) was found
in vessels along the iris stroma (Figure 4: D1, D2 and D3).
In the cornea, the immunoreactivity for vWF and VEGF
was observed in stromal vessels (Figure 4: G1, G2 and G3).
Neither the ST diabetic group nor the controls exhibited
immunoreactivity for vWF and VEGF in the retina, iris or
cornea (Figure 4: rows H and I).
The number of pericytes measured by the trypsin di-
gestive technique was found to be significantly lower in(G, H, I) from a LT-DBT animal (rows: A, D and G) and 57-week-old
unofluorescence of transverse retinal section for Von Willebrand antibody
3 yellow). In picture A1 the arrow points to the expression of vWF in fiber
w indicates an expression of VEGF in the OPL; in A3 there is a merge
antibodies (vWF and VEGF). In pictures D1, and D2 the arrows point to
w indicates an abnormal expression of vWF and VEGF in the corneal
section (B1, B2 and B3), iris (E1, E2 and E3) and cornea (H1, H2 and H3)
mal expression of VW and VEGF. LT-Control animals. Immunofluorescent
d F3; and cornea in I1, I2 and I3 for vWF antibody (green) and VEGF (red)
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(p = 0.0298 unpair t-test p < 0.05; Mean ± SEM of Control
0.08670 ± 0.003975 N = 31; Mean ± SEM of DBT group
0.07206 ± 0.005373 N = 21). Positive immunoreactivity for
GFAP was found in the FL and in cells morphologically
similar to Müller cells. Staining was much more extensive
in the LT diabetics than in the ST diabetics and controls
(Figure 5).
Discussion
We carried out an experimental study of diabetic retin-
opathy in an animal model of female type 2 diabetic rats
fed on an HFD. The animals developed retinal and cor-
neal neovascularization, as well as rubeosis iridis, after
110 weeks (two years) of diabetes. To our knowledge, this
is the first report on ocular neovascularization in type 2
diabetic rats fed on an HFD.
Animal models are extremely important for the ad-
vancement of science and from time to time researchers
report new models of diseases. However, the complexity
of some diseases makes this task difficult, particularly
when both systemic and local factors contribute to
the illness, as in the case of diabetic retinopathy. An-
other element to consider is the cost of animal models,
which should be reasonable. Big animals are expen-
sive and difficult for researchers to afford [4]. So, these as-
pects convinced us to opt for the rat model of type 2
diabetes fed on an HFD. This model was previously char-
acterised by other investigators [16,20] and recommendedFigure 5 Additional studies. Tripsin digestive technique of the retina (A,
capillary-net from a retina between middle size vessels. Arrow points to pe
capillary area was determined as indicated in methods section. Results are me
retinal sections with GFAP immunostaining from LT-DBT rats (D), ST-DBT rats
fibre layer and in cells with the morphology and spatial organisation of Müllefor studies on diabetic complications associated with
obesity [21].
It should be mentioned that we did not find prolifera-
tive retinopathy changes in a previous study carried out
in male type 2 diabetic rats of 90 weeks of disease, who
were also fed on an HFD (unpublished data). Although
the duration of diabetes is five months longer in this sur-
vey of female rats, other factors can lead to the growth
of proliferative changes in these animals. The potential
influence of oestrogens in the progression of diabetes in
rats is known [22] and this is possibly enhanced by de-
pletion of SHBG in female rats. It has been reported that
female rats are less sensitive to insulin than males of all
age groups and also more susceptible to the rapid develop-
ment of a severe form of diabetes. This is still controver-
sial in the scientific literature. In any case, the existence of
sex receptors in the rat eye may play a role in retinopathy
development. These receptors are also found in the hu-
man eye [23,24]. The chemical compound of the HFD
used in our research studies in male and female diabetic
rats was the same and we know that this type of diet in-
creases the risk of cardiovascular disease and promotes
cell damage [25-27]. So, an early onset of diabetes (STZ
injection at day two, followed by HFD at eight weeks on-
wards), a longer duration, known clinical risk factors and
female sex might have been key elements in the develop-
ment of ocular neovascularization.
The first retinal morphological changes observed in
diabetic rats described in the scientific literature includedB). A, LT-DBT capillary-net, arrows point to acellular capilary. B: vascular
ricytes and arrowhead to endothelial cells. C, Number of pericytes per
an ± SEM of five rats in each group. *P <0.05. D, E and F are transverse
(E) and controls (F). Diabetic retinas (D and E) overexpressed GFAP in the
r cells. Bar 50 μm.
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capillaries. These changes lead to retinal ischaemia [28].
We found a significantly lower number of pericytes in LT
diabetic rats than in the controls, which is in accordance
with previous studies.
In our survey, the morphology of pre-retinal neovascu-
larization was consistent with that reported by other au-
thors [3,29,30]. Intra-retinal neovessels were seen in the
inner part of the retina (Figure 2). This type of vessel al-
ways shows positive immunoreactivity of the vWF Factor
and VEGF as well as co-localisation of them. It is known
that vWF is a marker of endothelial dysfunction and
widely used to study angiogenesis in cancer and ocular
diseases [31,32]. Staining of this marker was not seen in
the vessels of the ST diabetics and controls. It should be
noted that all LT diabetic animals had pre-retinal and/or
intra-retinal neovessels. Similarly, all LT diabetics showed
a thick iris, as well as rubeosis iridis, a known consequence
of severe retinal hypoxia and the release of angiogenic fac-
tors that lead to neovascular glaucoma in humans. This, in
turn, can cause corneal endothelial dysfunction with bul-
lous keratopathy, corneal edema and epithelial erosions,
release of inflammatory cytokines, limbal stem cells defi-
ciency and corneal neovascularization, which was clinically
observed in three of the LT diabetic animals in our study.
Conclusions
An animal model mimics a human disease and it can be
considered as a platform for the study of mechanisms and
therapeutic agents. For this reason, several models have
been developed in ophthalmology, such as the oxygen-
induced retinopathy model [33] and the proliferative dia-
betic retinopathy model using gene therapy [30]. In our
model, the streptozotocin injection, HFD, earlier onset and
longer duration of diabetes and probably female sex are
considered major contributing factors to disease growth.
Future investigations will confirm the usefulness of this
diabetic retinopathy animal model.
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